HK1115500A1 - Isoquinolines as igf-1r inhibitors - Google Patents
Isoquinolines as igf-1r inhibitorsInfo
- Publication number
- HK1115500A1 HK1115500A1 HK08110849.4A HK08110849A HK1115500A1 HK 1115500 A1 HK1115500 A1 HK 1115500A1 HK 08110849 A HK08110849 A HK 08110849A HK 1115500 A1 HK1115500 A1 HK 1115500A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- igf
- isoquinolines
- inhibitors
- receptor
- inhibit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2005002701 | 2005-09-09 | ||
PCT/IB2006/002473 WO2007029106A1 (en) | 2005-09-09 | 2006-09-08 | Isoquinolines as igf-1r inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1115500A1 true HK1115500A1 (en) | 2008-11-28 |
Family
ID=36350070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08110849.4A HK1115500A1 (en) | 2005-09-09 | 2008-09-29 | Isoquinolines as igf-1r inhibitors |
Country Status (19)
Country | Link |
---|---|
US (1) | US8044067B2 (ru) |
EP (1) | EP1931636B1 (ru) |
JP (1) | JP2009507819A (ru) |
KR (1) | KR20080042897A (ru) |
CN (1) | CN101258130B (ru) |
AT (1) | ATE505457T1 (ru) |
AU (1) | AU2006288846B2 (ru) |
BR (1) | BRPI0616732A2 (ru) |
CA (1) | CA2621836C (ru) |
DE (1) | DE602006021327D1 (ru) |
DK (1) | DK1931636T3 (ru) |
EA (1) | EA200800785A1 (ru) |
ES (1) | ES2364673T3 (ru) |
HK (1) | HK1115500A1 (ru) |
IL (1) | IL189883A (ru) |
NO (1) | NO20081207L (ru) |
NZ (1) | NZ566524A (ru) |
WO (1) | WO2007029106A1 (ru) |
ZA (1) | ZA200801875B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2544672A1 (en) | 2010-03-09 | 2013-01-16 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
JP2014510265A (ja) | 2011-02-02 | 2014-04-24 | アムジェン インコーポレイテッド | Igf−1rの阻害に関する方法および組成物 |
CN103732592A (zh) * | 2011-04-21 | 2014-04-16 | 默沙东公司 | 胰岛素样生长因子-1受体抑制剂 |
AU2012335541B2 (en) | 2011-11-11 | 2017-07-06 | Duke University | Combination drug therapy for the treatment of solid tumors |
US8980259B2 (en) | 2012-07-20 | 2015-03-17 | Novartis Ag | Combination therapy |
CN104672136B (zh) * | 2013-11-30 | 2017-01-25 | 沈阳药科大学 | 1‑取代菲基‑n‑烷基(酰基)‑6,7‑二甲氧基‑1,2,3,4‑四氢异喹啉衍生物及其制备方法和用途 |
WO2017129763A1 (en) | 2016-01-28 | 2017-08-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of signet ring cell gastric cancer |
EP3941905A1 (en) * | 2019-03-19 | 2022-01-26 | Suvalent Therapeutics, Inc. | Sumo inhibitor compounds and uses thereof |
CN114456184B (zh) * | 2022-02-21 | 2023-08-22 | 南华大学附属第一医院 | 一种3-芳基异喹啉衍生物及其制备与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100878855B1 (ko) * | 1999-11-03 | 2009-01-15 | 에이엠알 테크놀로지, 인크. | 4-페닐-치환 테트라히드로이소퀴놀린, 및 노르에피네프린과 도파민과 세로토닌의 재흡수를 차단하기 위한 이의 용도 |
SE0203746D0 (sv) * | 2002-12-18 | 2002-12-18 | Karolinska Innovations Ab | New compounds |
EA200601687A1 (ru) * | 2004-03-12 | 2007-04-27 | Аналитикон С.А. | Тетрагидроизохинолиновые и тетрагидробензазепиновые производные (варианты), фармацевтическая композиция и фармацевтический набор, лекарственное и эталонное средство для тест-систем на их основе, способ лечения и профилактики заболевания, при котором благоприятна понижающая регуляция или ингибирование экспрессии или функции рецептора igf-1 |
-
2006
- 2006-09-08 US US11/991,431 patent/US8044067B2/en not_active Expired - Fee Related
- 2006-09-08 WO PCT/IB2006/002473 patent/WO2007029106A1/en active Application Filing
- 2006-09-08 KR KR1020087006671A patent/KR20080042897A/ko not_active Application Discontinuation
- 2006-09-08 AU AU2006288846A patent/AU2006288846B2/en not_active Ceased
- 2006-09-08 EA EA200800785A patent/EA200800785A1/ru unknown
- 2006-09-08 DE DE602006021327T patent/DE602006021327D1/de active Active
- 2006-09-08 EP EP06795448A patent/EP1931636B1/en active Active
- 2006-09-08 CA CA2621836A patent/CA2621836C/en not_active Expired - Fee Related
- 2006-09-08 JP JP2008529710A patent/JP2009507819A/ja active Pending
- 2006-09-08 BR BRPI0616732-2A patent/BRPI0616732A2/pt active Search and Examination
- 2006-09-08 CN CN2006800329830A patent/CN101258130B/zh not_active Expired - Fee Related
- 2006-09-08 DK DK06795448.7T patent/DK1931636T3/da active
- 2006-09-08 NZ NZ566524A patent/NZ566524A/en not_active IP Right Cessation
- 2006-09-08 ES ES06795448T patent/ES2364673T3/es active Active
- 2006-09-08 AT AT06795448T patent/ATE505457T1/de not_active IP Right Cessation
-
2008
- 2008-02-28 ZA ZA200801875A patent/ZA200801875B/xx unknown
- 2008-03-02 IL IL189883A patent/IL189883A/en not_active IP Right Cessation
- 2008-03-07 NO NO20081207A patent/NO20081207L/no not_active Application Discontinuation
- 2008-09-29 HK HK08110849.4A patent/HK1115500A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1931636A1 (en) | 2008-06-18 |
CA2621836C (en) | 2013-11-12 |
EA200800785A1 (ru) | 2008-08-29 |
EP1931636B1 (en) | 2011-04-13 |
US8044067B2 (en) | 2011-10-25 |
JP2009507819A (ja) | 2009-02-26 |
BRPI0616732A2 (pt) | 2013-01-01 |
US20090099229A1 (en) | 2009-04-16 |
ES2364673T3 (es) | 2011-09-12 |
WO2007029106A1 (en) | 2007-03-15 |
AU2006288846A1 (en) | 2007-03-15 |
ZA200801875B (en) | 2009-08-26 |
KR20080042897A (ko) | 2008-05-15 |
DE602006021327D1 (de) | 2011-05-26 |
NZ566524A (en) | 2011-01-28 |
IL189883A (en) | 2012-07-31 |
DK1931636T3 (da) | 2011-07-25 |
CN101258130A (zh) | 2008-09-03 |
AU2006288846B2 (en) | 2011-08-18 |
IL189883A0 (en) | 2008-11-03 |
NO20081207L (no) | 2008-05-27 |
CA2621836A1 (en) | 2007-03-15 |
CN101258130B (zh) | 2012-11-28 |
ATE505457T1 (de) | 2011-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1115500A1 (en) | Isoquinolines as igf-1r inhibitors | |
TN2011000279A1 (en) | Novel pyrazole -4-n-alkoxycarboxamides as microbiocides | |
MX2009010595A (es) | Derivados de pirrolopirimidina. | |
MX2009005934A (es) | Compuestos organicos. | |
TW200626610A (en) | Analogs of 17-hydroxywortmannin as PI3K inhibitors | |
TN2010000101A1 (en) | Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives | |
WO2007085895A3 (en) | Fap inhibitors | |
GEP20125564B (en) | Pyrimidine derivatives as kinase inhibitors | |
MX2009003834A (es) | Derivados de pirrolidina como inhibidores de iap. | |
MX2009004888A (es) | Inhibidores del virus de la hepatitis c. | |
MX2009007302A (es) | Derivados de purina. | |
TW200800956A (en) | 2-Aminopyrimidine derivatives | |
UA103625C2 (en) | 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides | |
WO2009024342A3 (en) | Novel microbiocides | |
EA024194B8 (ru) | Содержащие диарилацетиленгидразид ингибиторы тирозинкиназы | |
MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
PT1877367E (pt) | Derivados do acetileno | |
TW200619206A (en) | Chemokine-binding heterocyclic compound salts, and methods of use thereof | |
WO2008151828A8 (en) | Novel microbiocides | |
WO2009127718A3 (en) | Novel microbiocides | |
NO20081206L (no) | Isoquinolines derivatives as IGF -1R inhibitors | |
MX2010006787A (es) | Análogos halogenados de agentes anti-fibroticos. | |
TW200738713A (en) | Diazepinoquinolines, synthesis thereof, and intermediates thereto | |
TN2011000355A1 (en) | Novel microbiocides | |
WO2009003672A3 (en) | Novel microbiocides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180908 |